Welcome to LookChem.com Sign In|Join Free

CAS

  • or

205386-57-8

Post Buying Request

205386-57-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

205386-57-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 205386-57-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,3,8 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 205386-57:
(8*2)+(7*0)+(6*5)+(5*3)+(4*8)+(3*6)+(2*5)+(1*7)=128
128 % 10 = 8
So 205386-57-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO5/c1-6(2)4-11-8-12(16,9(15)13-11)7(14)5-10(3,17-8)18-11/h6,8,16H,4-5H2,1-3H3,(H,13,15)/t8-,10+,11+,12+/m0/s1

205386-57-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Rubrobramide

1.2 Other means of identification

Product number -
Other names 2,7-Epoxypyrano(2,3-c)pyrrole-4,5-dione,hexahydro-4a-hydroxy-2-methyl-7-(2-methylpropyl)-,(2R,4aS,7R,7aR)-rel-( )

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:205386-57-8 SDS

205386-57-8Upstream product

205386-57-8Downstream Products

205386-57-8Relevant articles and documents

A Bioinspired Synthesis of (±)-Rubrobramide, (±)-Flavipucine, and (±)-Isoflavipucine

Mizutani, Shoma,Komori, Kenta,Taniguchi, Tohru,Monde, Kenji,Kuramochi, Kouji,Tsubaki, Kazunori

, p. 9553 - 9556 (2016)

A biomimetic synthesis of naturally occurring lactams rubrobramide, flavipucine, and isoflavipucine is described. The key step is a regioselective Darzens reaction between isobutyl glyoxal and an α-bromo-β-ketoamide. The construction of the core tricyclic ring system of rubrobramide was achieved by a cascade reaction in a single step from an α,β-epoxy-γ-lactam. Furthermore, the absolute configuration of naturally occurring (+)-rubrobramide was determined by vibrational circular dichroism. (±)-Flavipucine and (±)-isoflavipucine were synthesized from an epoxyimide, which was prepared by reaction of isobutyl glyoxal with a protected α-bromo-β-ketoamide. Deprotection of the epoxyimide and formation of the pyridone ring gave (±)-flavipucine, which was converted into (±)-isoflavipucine by thermal isomerization.

Enantioselective total synthesis of (+)-rubrobramide, (+)-talaramide A, and (?)-berkeleyamide D by a skeletal diversification strategy

Tanaka, Kosaku,Kobayashi, Kenichi,Kogen, Hiroshi

supporting information, p. 9780 - 9783 (2021/09/30)

A unified synthesis of (+)-rubrobramide, (+)-talaramide A, and (?)-berkeleyamide D was achieved from the vinylogous esters by a skeletal diversification strategy based on regioselective 5-exoor 6-endocyclization. This report describes the first enantioselective total synthesis of (+)-rubrobramide and (+)-talaramide A. Additionally, synthetic spirocyclic lactam compounds, including (?)-berkeleyamide D, showed moderate inhibitory activity against amyloid-β aggregation for the potential treatment of Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 205386-57-8